Nucleic Acid Drugs and DNA-based Delivery Systems

Area of Science:

• Biochemistry
• Materials Science
• Drug Delivery

Background:

• Nucleic acids, including DNA, are biologically active and serve as foundational materials for advanced therapeutic applications.
• Chemically modified nucleic acids offer enhanced properties for nucleic acid drugs and DNA-based delivery systems like hydrogels.
• The integration of modified nucleic acids presents opportunities for increased therapeutic potency.

Purpose of the Study:

• To highlight the potential of chemically modified nucleic acids in drug delivery systems.
• To address the challenges associated with the physicochemical properties and synthesis costs of modified nucleic acids.
• To emphasize the importance of cost reduction for the widespread adoption of nucleic acid-based therapeutics.

Main Methods:

• Review of the properties and applications of natural and chemically modified nucleic acids.
• Analysis of DNA-based delivery systems, including hydrogels.
• Discussion on the economic factors influencing the development and use of modified oligonucleotides.

Main Results:

• Chemically modified nucleic acids can significantly boost the therapeutic efficacy of DNA delivery systems.
• Differences in physicochemical properties between natural and modified nucleic acids require careful consideration.
• The high cost of synthesizing modified oligonucleotides is a major barrier to clinical and commercial use.

Conclusions:

• Chemically modified nucleic acids hold great promise for advancing nucleic acid drugs and DNA-based delivery platforms.
• Addressing the synthesis cost is paramount for unlocking the full potential of these technologies.
• Further research into cost-effective synthesis methods is crucial for the expanded use of modified nucleic acids in medicine.